| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/16/2004 | WO2004079013A1 Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer |
| 09/16/2004 | WO2004079012A1 Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer |
| 09/16/2004 | WO2004079011A1 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004079010A1 Use of il10 haplotypes for predicting susceptibility to progression of hbv to hcc |
| 09/16/2004 | WO2004079009A1 Dna amplification method and kit therefor |
| 09/16/2004 | WO2004079008A1 Screening method for genes of brewing yeast |
| 09/16/2004 | WO2004079007A2 Time-lapse cell analysis method |
| 09/16/2004 | WO2004079006A1 Method for identifying the function of a gene |
| 09/16/2004 | WO2004079005A1 Method and device for integrated nucleic acid integrity assessment and analysis |
| 09/16/2004 | WO2004079004A1 Method for the identification of colorectal tumors |
| 09/16/2004 | WO2004079003A1 Sgk1 as diagnostic and therapeutic target |
| 09/16/2004 | WO2004079002A1 Lab-on-chip system for analying nucleic acid |
| 09/16/2004 | WO2004079001A1 Nucleic acid mismatch detection |
| 09/16/2004 | WO2004079000A1 The determination of function of mammalian proteins by analysis of global gene expression profiles |
| 09/16/2004 | WO2004078999A1 Identification of fetal dna and fetal cell markers in maternal plasma or serum |
| 09/16/2004 | WO2004078998A1 Fluorescence polarization assay for determining binding of a test compound to pdhk (pyruvate dehydrogenase kinase) |
| 09/16/2004 | WO2004078997A2 Method for detecting micro-organisms in an electrocoating process |
| 09/16/2004 | WO2004078996A1 Method of detecting biological weapon use by monitoring a monolayer |
| 09/16/2004 | WO2004078994A2 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078992A2 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics |
| 09/16/2004 | WO2004078991A2 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 09/16/2004 | WO2004078985A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078984A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078980A1 Nucleic acid and method of examining canceration using the nucleic acid |
| 09/16/2004 | WO2004078975A1 Novel protein and use thereof |
| 09/16/2004 | WO2004078963A1 Method of examining steroid response |
| 09/16/2004 | WO2004078950A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |
| 09/16/2004 | WO2004078948A2 METHOD TO IDENTIFY REGULATORS OF CELLULAR ACTIVATION USING Bcl10 |
| 09/16/2004 | WO2004078943A2 Alternative heterocycles for dna recognition |
| 09/16/2004 | WO2004078941A2 Modulation of gene expression using dna-rna hybrids |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 09/16/2004 | WO2004078929A2 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078907A2 Streptococcus pyogenes antigens |
| 09/16/2004 | WO2004078713A2 Morpholino based activity mapping |
| 09/16/2004 | WO2004078594A2 Ligand/binding partner bio-labeling systems |
| 09/16/2004 | WO2004078141A2 Hemipteran membrane-bound matrix metalloproteinase |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078035A2 Expression profiles for breast cancer and methods of use |
| 09/16/2004 | WO2004078022A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | WO2004078020A2 Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of mrd in leukemia |
| 09/16/2004 | WO2004072227A3 Animal testing procedure |
| 09/16/2004 | WO2004063392A3 Selective culture medium for the isolation and/or detection of species in the streptococcus genus |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004055199A3 A biological sample storage device and method for biological sample contamination testing |
| 09/16/2004 | WO2004052278A3 Escape mutants of newcastle disease virus as marker vaccines |
| 09/16/2004 | WO2004048928A3 Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two-dimensional array |
| 09/16/2004 | WO2004048544A3 Ca ix-specific inhibitors |
| 09/16/2004 | WO2004048256A3 Separation of carbon nanotubes dispersed by nucleic acids |
| 09/16/2004 | WO2004047731A8 Modulation of notch3 expression |
| 09/16/2004 | WO2004046378A3 Microarray-based method for amplifying and detecting nucleic acids during a continuous process |
| 09/16/2004 | WO2004046376A3 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 09/16/2004 | WO2004040017A3 Assay method for detecting fungal infection of soil or vegetables |
| 09/16/2004 | WO2004035597A3 Methods of assessing the risk of reproductive failure by measuring telomere length |
| 09/16/2004 | WO2004027080A3 Method of extracting nucleic acids from microbial samples |
| 09/16/2004 | WO2004027018A3 Inducible focal adhesion kinase cell assay |
| 09/16/2004 | WO2004024944A3 Method and nucleotide sequences for the detection and identification of micro-organisms in a complex mixture or water |
| 09/16/2004 | WO2004022721A3 Quantification of gene expression |
| 09/16/2004 | WO2004013291A3 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli |
| 09/16/2004 | WO2004011938B1 Method and device for screening molecules in cells |
| 09/16/2004 | WO2004009791A3 Modulators of b-lymphocyte activation, myosin-1f compositions and methods of use |
| 09/16/2004 | WO2004007759A3 Identification method for verifying the authenticity of an object |
| 09/16/2004 | WO2004005540A3 Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |
| 09/16/2004 | WO2003102212A9 In vitro evaluation of nucleic acid ligands |
| 09/16/2004 | WO2003100012A3 Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| 09/16/2004 | WO2003089901A3 Methods for preparing libraries of unique tags and related screening methods |
| 09/16/2004 | WO2003086299A3 Quantitative assay of the angiogenic and antiangiogenic activity of a test molecule |
| 09/16/2004 | WO2003085378A3 Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction |
| 09/16/2004 | WO2003081239A3 Treating cancer |
| 09/16/2004 | WO2003074657A3 Cold shock inducible expression and production of heterologous polypeptides |
| 09/16/2004 | WO2003070746A3 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003046130A3 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003040168A3 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 09/16/2004 | WO2003033668A3 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis |
| 09/16/2004 | WO2003006677A3 Multiplex nucleic acid reactions |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | WO2002099043A8 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/16/2004 | WO2002092002A3 Screening, diagnostic and therapeutic methods relating to riz |
| 09/16/2004 | WO2002069691A3 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/16/2004 | WO2002068537A3 Fluorescent dye |
| 09/16/2004 | US20040181048 can discriminate between alleles in conventional allelic discrimination assays; for prevention/treatment of cancer/tumors |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181045 Antisense nucleotide sequences for treatment, diagnosis and prevention of viral and autoimmune disorders |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040180957 rescuing damaged nerve cells; kits and instructions for administering |
| 09/16/2004 | US20040180927 Inhibitors of cysteine protease |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180828 Apoptosis suppression; polypeptides of sequence 2 having surface groove including amino acid residues P325, G326, H343 and L344 |
| 09/16/2004 | US20040180813 4-Amino acid functionalized-2-pyrophosphatyl-pyranes; direct assay, high throughput screening for enzyme inhibitors; N-acetylglucosaminyltransferase |
| 09/16/2004 | US20040180445 Methods and compositions for purification of nucleic acid from a host cell |
| 09/16/2004 | US20040180428 Automated apparatus for injecting sample of gene, pigment, protein, peptide or drug into oocytes of frogs using pipette-like needle; tissue engineering |
| 09/16/2004 | US20040180412 Evolving new molecular function |
| 09/16/2004 | US20040180401 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 09/16/2004 | US20040180396 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |